What is Bangkok Dusit Medical Services PCL Altman Z-Score?
Bangkok Dusit Medical Services PCLBKK:BDMS +2.07%92 Altman Z-Score is 5.74 as of Jul. 02, 2026, which is 5% below its 10-year median of 6.03. GuruFocus rates BKK:BDMS with a GF Score™ of 92/100 and a GF Value™ of ฿28.07 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 78.79% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 5.57 is strong.
Bangkok Dusit Medical Services PCL has a Altman Z-Score of 5.74, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
BKK:BDMS'
s Altman Z-Score Range Over the Past 10 Years
Min: 4.31 Med: 6.03 Max: 8.04
Current: 5.57
During the past 13 years, Bangkok Dusit Medical Services PCL's highest Altman Z-Score was 8.04. The lowest was 4.31. And the median was 6.03.
Bangkok Dusit Medical Services PCL (BKK:BDMS) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL Altman Z-Score Chart
BKK:BDMS vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's Altman Z-Score falls into.
Bangkok Dusit Medical Services PCL Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Bangkok Dusit Medical Services PCL (BKK:BDMS) has a Altman Z-Score of 5.74 as of Jul. 02, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is near median its historical median of 6.03. Over the past decade, Bangkok Dusit Medical Services PCL's Altman Z-Score has ranged from 4.31 to 8.04. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #140 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 21.2%.
Is Bangkok Dusit Medical Services PCL's Altman Z-Score too high?
Bangkok Dusit Medical Services PCL's current Altman Z-Score of 5.74 is near median its 10-year median of 6.03. Over the past 10 years, this metric has ranged from a low of 4.31 to a high of 8.04. The Healthcare Providers & Services industry median Altman Z-Score is 2.42. Bangkok Dusit Medical Services PCL's value of 5.74 is 137.2% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #140 out of 660 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #140 out of 660 companies for Altman Z-Score. This places Bangkok Dusit Medical Services PCL in the top 21% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.42. Bangkok Dusit Medical Services PCL's value of 5.74 is 137.2% above this benchmark. Historically, Bangkok Dusit Medical Services PCL's own Altman Z-Score has ranged from 4.31 to 8.04 over the past decade. While the company's 10-year median is 6.03 vs. the industry median of 2.42, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.42, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current Altman Z-Score of 5.74 is 137.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current Altman Z-Score is 5.74, which is near median its own 10-year median of 6.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BKK:BDMS) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿28.07, compared to a current price of ฿19.70 — trading 29.8% below its estimated fair value. The current Altman Z-Score is 5.74, which is near median its 10-year median of 6.03 and 137.2% above the Healthcare Providers & Services industry median of 2.42. Bangkok Dusit Medical Services PCL's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BKK:BDMS), the current Altman Z-Score is 5.74 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BKK:BDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of ฿19.70 is trading 29.8% below its estimated GF Value™ of ฿28.07.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BKK:BDMS:
Altman Z-Score: 5.74 (near median its 10-year median of 6.03)
GF Value™: ฿28.07 vs. price of ฿19.70 (29.8% below fair value)
Industry Position: 137.2% above the Healthcare Providers & Services median (#140 of 660)
No single metric tells the full story. See the BKK:BDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
92GF Score
Get the complete analysis for BKK:BDMS
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BDMS has been successfully added to your 
